Rasuvo 30mg/0.6ml Pf Inj, 4 Pens
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin, typically on the top of the thigh or in the belly area. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Important Administration Guidelines
Do not inject the medication within 2 inches (5 cm) of the belly button.
Check the solution for cloudiness, leakage, or particles before use; do not use if any of these issues are present.
Avoid injecting into skin that is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
If you are unsure whether a dose was injected correctly or experience difficulty administering the dose, consult your doctor or pharmacist before proceeding with another dose.
Safe Disposal of Needles and Supplies
Dispose of used needles in a designated needle/sharp disposal box.
Do not reuse needles or other items.
When the disposal box is full, follow local regulations for proper disposal.
If you have questions or concerns, consult your doctor or pharmacist.
Dosing and Frequency
Your dosage and frequency of administration will be determined by your doctor based on the specific health condition being treated.
Important: This medication should never be taken daily unless prescribed for certain types of cancer. Incorrect use can lead to fatal errors. Ensure you understand your dosage and administration schedule; if unclear, consult your doctor.
Your doctor may adjust the dosage or administration schedule based on blood work results, side effects, and the medication's effectiveness.
Handling and Storage
Handle this medication with care; consult your doctor or pharmacist for specific guidance.
Drink plenty of non-caffeinated liquids, unless your doctor advises you to limit fluid intake.
Storage and Disposal
Store the medication at room temperature, protected from light, and in a dry place.
Do not store in a bathroom.
Missed Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Take exactly as prescribed, usually once a week. Do NOT take daily.
- Take folic acid or leucovorin as prescribed by your doctor to reduce side effects.
- Avoid alcohol completely due to increased risk of liver damage.
- Avoid excessive sun exposure and use sunscreen, as methotrexate can increase sun sensitivity.
- Use effective contraception during treatment and for at least 6 months after stopping for both men and women, as it can cause birth defects.
- Avoid live vaccines while on methotrexate.
- Stay well-hydrated.
- Report any signs of infection, unusual bleeding/bruising, severe fatigue, shortness of breath, or yellowing of skin/eyes immediately.
Available Forms & Alternatives
Available Strengths:
- Rasuvo 10mg/0.2ml Pf Inj, 4 Pens
- Rasuvo 12.5mg/0.25ml Pf Inj, 4 Pens
- Rasuvo 22.5mg/0.45ml Pf Inj, 4 Pens
- Rasuvo 25mg/0.5ml Pf Inj, 4 Pens
- Rasuvo 15mg/0.3ml Pf Inj, 4 Pens
- Rasuvo 17.5mg/0.35ml Pf Inj, 4 Pens
- Rasuvo 20mg/0.4ml Pf Inj, 4 Pens
- Rasuvo 30mg/0.6ml Pf Inj, 4 Pens
- Rasuvo 7.5mg/0.15ml Pf Inj, 4 Pens
- Rasuvo 15mg Inj, 0.3ml
- Rasuvo 17.5mg Inj, 0.35ml
- Rasuvo 20mg Inj, 0.4ml
- Rasuvo 7.5mg Inj, 0.15ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Infection: Fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal.
Bleeding: Vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, gum bleeding, abnormal vaginal bleeding, unexplained bruises or bruises that enlarge, or uncontrollable bleeding.
Pancreatitis: Severe stomach pain, severe back pain, or severe nausea and vomiting.
Kidney Problems: Inability to urinate, changes in urine output, blood in the urine, or sudden weight gain.
Liver Problems: Dark urine, fatigue, decreased appetite, nausea or stomach pain, light-colored stools, vomiting, or yellow skin and eyes.
Lung or Breathing Problems: Shortness of breath, breathing difficulties, cough, or fever.
Nerve Problems: Abnormal burning, numbness, or tingling sensations, weakness, or paralysis.
Other Severe Symptoms: Pinpoint red spots on the skin, severe dizziness or fainting, seizures, confusion, excessive sleepiness, changes in vision, bone pain, or swelling, warmth, numbness, color changes, or pain in a leg or arm.
Stroke-Like Symptoms: Weakness on one side of the body, speech or thinking difficulties, balance changes, facial drooping, or blurred vision.
Other Concerning Symptoms: Headache, neck stiffness.
Common Side Effects
Most people experience minimal or no side effects. However, if you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:
Decreased appetite
Hair loss
Dizziness, fatigue, or weakness
Stomach pain
Common cold symptoms
Reporting Side Effects
This is not an exhaustive list of potential side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, chills, sore throat, or other signs of infection
- Unusual bleeding or bruising
- Severe fatigue or weakness
- Shortness of breath or persistent dry cough
- Yellowing of skin or eyes (jaundice)
- Dark urine or pale stools
- Severe nausea, vomiting, or diarrhea
- Mouth sores or ulcers
- Severe skin rash or blistering
- Swelling in ankles or feet
- Severe headache or confusion
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Alcohol use disorder
+ Bone marrow disease, such as low white blood cell count, low platelet count, or anemia
+ Kidney disease
+ Liver disease
+ A weakened immune system
If you are breast-feeding, please note that you should not breast-feed while taking this medication. Additionally, you may need to avoid breast-feeding for a period after your last dose. Consult your doctor to determine the necessary duration.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure that it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
When starting this drug, be cautious and avoid driving or engaging in activities that require alertness until you understand how it affects you. You may be more susceptible to infections, so it is crucial to practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.
Be aware that you may experience easier bleeding, so it is vital to be careful and avoid injuries. To minimize the risk of bleeding, use a soft toothbrush and an electric razor for shaving.
Before receiving any vaccinations, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication. Additionally, discuss your alcohol consumption with your doctor before drinking.
You may be more prone to sunburn, so it is recommended to avoid direct sunlight, sunlamps, and tanning beds. Use sunscreen and wear protective clothing and eyewear to safeguard yourself against the sun's harmful effects. Continue to take sun protection measures for as long as advised by your doctor.
If you experience excessive fluid loss, unusual sweating, vomiting, diarrhea, decreased appetite, or unusual thirst, notify your doctor promptly. This medication can cause severe nervous system problems, which may be temporary or long-lasting and can worsen over time. In some cases, these problems may not improve and can be life-threatening. If you have concerns, discuss them with your doctor.
If you have undergone radiation therapy, inform your doctor, as this may affect your treatment. Elderly patients (65 years or older) should use this medication with caution, as they may be more susceptible to side effects.
This drug may impact fertility, potentially leading to difficulty conceiving or fathering a child. It is unclear whether fertility will return to normal if this occurs. If you miss a menstrual period, have unprotected sex, or suspect that your birth control has failed, contact your doctor immediately.
Overdose Information
Overdose Symptoms:
- Severe bone marrow suppression (low white blood cells, red blood cells, platelets)
- Severe mucositis (mouth sores, GI ulcers)
- Severe liver damage
- Kidney failure
What to Do:
Immediately contact your doctor or go to the nearest emergency room. Leucovorin rescue is the primary antidote, administered as soon as possible. Glucarpidase may be used in cases of delayed methotrexate clearance due to renal impairment.
Drug Interactions
Contraindicated Interactions
- Live vaccines (due to immunosuppression)
- Pemetrexed (concurrent use may increase methotrexate toxicity)
- Probenecid (decreases renal excretion of methotrexate)
- NSAIDs/Salicylates (high dose methotrexate, risk of severe toxicity)
- Trimethoprim/Sulfamethoxazole (increased risk of bone marrow suppression)
- Alcohol (increased risk of hepatotoxicity)
Major Interactions
- NSAIDs/Salicylates (low dose methotrexate, increased risk of toxicity, monitor closely)
- Proton Pump Inhibitors (PPIs) (e.g., omeprazole, esomeprazole - may increase methotrexate levels, especially at higher doses)
- Penicillins (e.g., amoxicillin, penicillin G - may decrease renal clearance of methotrexate)
- Sulfonamides (e.g., sulfasalazine - may displace methotrexate from protein binding, increase free methotrexate)
- Folic acid antagonists (e.g., trimethoprim, pyrimethamine - additive bone marrow suppression)
- Retinoids (e.g., acitretin - increased risk of hepatotoxicity)
- Phenytoin (may decrease phenytoin levels, or methotrexate toxicity may be increased)
- Theophylline (methotrexate may decrease theophylline clearance)
- Chloramphenicol, tetracyclines (may interfere with enterohepatic recirculation, increasing methotrexate levels)
Moderate Interactions
- Ciprofloxacin (may decrease methotrexate clearance)
- Oral antibiotics (may alter gut flora, affecting enterohepatic recirculation)
- Colchicine (increased risk of myelosuppression)
- Hydroxychloroquine (may increase intracellular methotrexate levels)
- Leflunomide (increased risk of hepatotoxicity and myelosuppression)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic status and detect pre-existing cytopenias. Methotrexate can cause myelosuppression.
Timing: Prior to initiation of therapy
Rationale: To establish baseline hepatic function. Methotrexate is hepatotoxic.
Timing: Prior to initiation of therapy
Rationale: To establish baseline renal function. Methotrexate is primarily renally excreted, and impaired renal function increases toxicity.
Timing: Prior to initiation of therapy
Rationale: To rule out pre-existing pulmonary disease. Methotrexate can cause pulmonary toxicity.
Timing: Prior to initiation of therapy
Rationale: To screen for chronic viral hepatitis, which may increase risk of hepatotoxicity.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Every 2-4 weeks for the first 3 months, then every 1-2 months.
Target: WBC >3.5 x 10^9/L, Neutrophils >1.5 x 10^9/L, Platelets >100 x 10^9/L, Hemoglobin >10 g/dL
Action Threshold: Hold dose if WBC <3.5 x 10^9/L, Neutrophils <1.5 x 10^9/L, Platelets <100 x 10^9/L, or significant drop in hemoglobin. Re-evaluate and consider dose reduction or discontinuation.
Frequency: Every 2-4 weeks for the first 3 months, then every 1-2 months.
Target: AST/ALT <2x upper limit of normal (ULN)
Action Threshold: Hold dose if AST/ALT >2x ULN on two consecutive measurements, or if albumin decreases significantly. Consider liver biopsy if persistent elevation or cumulative dose concerns.
Frequency: Every 2-4 weeks for the first 3 months, then every 1-2 months.
Target: Within normal limits, stable from baseline.
Action Threshold: Hold dose if creatinine increases by >50% from baseline or if eGFR drops significantly. Re-evaluate and consider dose reduction or discontinuation.
Symptom Monitoring
- Signs of infection (fever, chills, sore throat)
- Unusual bleeding or bruising
- Fatigue, weakness, pallor (anemia)
- Shortness of breath, dry cough (pulmonary toxicity)
- Nausea, vomiting, diarrhea, oral sores/mucositis
- Yellowing of skin or eyes, dark urine (hepatotoxicity)
- Skin rash, itching
- Hair loss
- Headache, dizziness
Special Patient Groups
Pregnancy
Contraindicated in pregnancy. Methotrexate is a known human teratogen and abortifacient. It can cause fetal death or severe birth defects.
Trimester-Specific Risks:
Lactation
Contraindicated during breastfeeding. Methotrexate is excreted into breast milk and can cause serious adverse reactions in a breastfed infant, including myelosuppression.
Pediatric Use
Used for Juvenile Idiopathic Arthritis (JIA) and certain pediatric cancers (e.g., acute lymphoblastic leukemia). Dosing is weight or body surface area-based. Close monitoring for toxicity is essential, similar to adults.
Geriatric Use
Use with caution. Elderly patients may have decreased renal and hepatic function, increasing the risk of methotrexate toxicity. More frequent monitoring of CBC, LFTs, and renal function is recommended. Start with lower doses and titrate carefully.
Clinical Information
Clinical Pearls
- Methotrexate is typically dosed ONCE WEEKLY for rheumatoid arthritis and psoriasis. Accidental daily dosing has led to fatal outcomes. Emphasize this to patients.
- Folic acid supplementation (usually 1-5 mg once daily, or 5 mg once weekly, taken on a different day than methotrexate) is crucial to reduce common side effects like nausea, mucositis, and liver enzyme elevations, without significantly impacting efficacy for inflammatory conditions.
- Ensure patients are adequately hydrated to minimize renal toxicity.
- Patients should be advised to avoid alcohol completely due to the risk of additive hepatotoxicity.
- Regular and diligent monitoring of CBC, LFTs, and renal function is paramount to detect and manage toxicity early.
- Subcutaneous administration often has better bioavailability and less GI side effects compared to oral administration, especially at higher doses.
- Counsel patients on the importance of contraception for both males and females during and for a significant period after treatment.
Alternative Therapies
- For Rheumatoid Arthritis: Other conventional DMARDs (e.g., sulfasalazine, hydroxychloroquine, leflunomide), Biologic DMARDs (e.g., TNF inhibitors like adalimumab, etanercept; IL-6 inhibitors like tocilizumab; T-cell costimulation modulators like abatacept; B-cell depleting agents like rituximab), JAK inhibitors (e.g., tofacitinib, baricitinib).
- For Psoriasis: Other systemic agents (e.g., cyclosporine, acitretin), Biologic agents (e.g., TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors), Oral small molecules (e.g., apremilast).
- For Oncology: Varies widely by cancer type and stage; other chemotherapeutic agents, targeted therapies, immunotherapies.